ABSTRACT Background: Chronic pain remains a significant challenge for modern health care as its pathologic mechanisms are largely unknown and preclinical animal models suffer from limitations in assessing this complex subjective experience. However, human brain neuroimaging techniques enable the ass

Background:Chronic pain remains a significant challenge for modern health care as its pathologic mechanisms are largely unknown and preclinical animal models suffer from limitations in assessing this complex subjective experience. However, human brain neuroimaging techniques enable the assessment of functional and neurochemical alterations in patients experiencing chronic pain and how these factors may dynamically change with pharmacologic treatment. Methods:To identify the clinical action of pregabalin, a proven analgesic, the authors performed three complementary brain neuroimaging procedures: (proton magnetic resonance spectroscopy, functional magnetic resonance imaging, and functional connectivity magnetic resonance imaging) in 17 chronic pain patients diagnosed with fibromyalgia. Results:The authors found that pregabalin but not placebo reduces combined glutamate + glutamine levels within the posterior insula (pregabalin P = 0.016; placebo P = 0.71). Interestingly, reductions in clinical pain were associated with reductions in brain connectivity of this structure to brain regions within the default mode network during pregabalin (r = 0.82; P = 0.001) but not placebo (r = −0.13; P = 0.63). Response of default mode network regions to experimental pain was also reduced with pregabalin (P = 0.018) but not placebo (P = 0.182). Perhaps most importantly, baseline values for all three neuroimaging markers predicted subsequent analgesic response to pregabalin but not placebo. Conclusions:The results of this study suggest that pregabalin works in part by reducing insular glutamatergic activity, leading to a reduction of the increased functional connectivity seen between brain regions in chronic pain states. The study also supports a role for human brain imaging in the development, assessment, and personalized use of central-acting analgesics.

[1]  C. Woolf,et al.  Central sensitization: a generator of pain hypersensitivity by central neural plasticity. , 2009, The journal of pain : official journal of the American Pain Society.

[2]  A. Apkarian,et al.  Chronic Back Pain Is Associated with Decreased Prefrontal and Thalamic Gray Matter Density , 2004, The Journal of Neuroscience.

[3]  J. Offord,et al.  The Novel Anticonvulsant Drug, Gabapentin (Neurontin), Binds to the Subunit of a Calcium Channel (*) , 1996, The Journal of Biological Chemistry.

[4]  Daniel J Clauw,et al.  Increased pain sensitivity in fibromyalgia: effects of stimulus type and mode of presentation , 2003, Pain.

[5]  Peter A. Bandettini,et al.  The respiration response function: The temporal dynamics of fMRI signal fluctuations related to changes in respiration , 2008, NeuroImage.

[6]  S. Borosky,et al.  Inhibition of K+-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin , 2000, Neuroscience Letters.

[7]  C. Woolf,et al.  Overcoming obstacles to developing new analgesics , 2010, Nature Medicine.

[8]  L. Chen.  Imaging of Pain , 2007, International anesthesiology clinics.

[9]  Bruce Fischl,et al.  Accurate and robust brain image alignment using boundary-based registration , 2009, NeuroImage.

[10]  D. Chialvo,et al.  Beyond Feeling: Chronic Pain Hurts the Brain, Disrupting the Default-Mode Network Dynamics , 2008, The Journal of Neuroscience.

[11]  Michael Brady,et al.  Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images , 2002, NeuroImage.

[12]  A Straube,et al.  Gray matter decrease in patients with chronic tension type headache , 2005, Neurology.

[13]  Stephen J. Smith,et al.  Gabapentin Receptor α2δ-1 Is a Neuronal Thrombospondin Receptor Responsible for Excitatory CNS Synaptogenesis , 2009, Cell.

[14]  Daniel J Clauw,et al.  Dynamic levels of glutamate within the insula are associated with improvements in multiple pain domains in fibromyalgia. , 2008, Arthritis and rheumatism.

[15]  Catie Chang,et al.  Influence of heart rate on the BOLD signal: The cardiac response function , 2009, NeuroImage.

[16]  T. Wager,et al.  Separate mechanisms for placebo and opiate analgesia? , 2010, Pain.

[17]  Stephen J. Smith,et al.  Gabapentin Receptor alpha 2 delta-1 Is a Neuronal Thrombospondin Receptor Responsible for Excitatory CNS Synaptogenesis , 2009 .

[18]  G. Woodruff,et al.  Characterisation of [3H]gabapentin binding to a novel site in rat brain: homogenate binding studies. , 1993, European journal of pharmacology.

[19]  H. Clusmann,et al.  Inhibition of neuronal Ca2+ influx by gabapentin and pregabalin in the human neocortex , 2002, Neuropharmacology.

[20]  Daniel J Clauw,et al.  Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. , 2002, Arthritis and rheumatism.

[21]  R. Poole,et al.  Pregabalin for the treatment of postherpetic neuralgia , 2003, Neurology.

[22]  Richard E. Harris,et al.  Decreased intrinsic brain connectivity is associated with reduced clinical pain in fibromyalgia. , 2012, Arthritis and rheumatism.

[23]  G H Glover,et al.  Image‐based method for retrospective correction of physiological motion effects in fMRI: RETROICOR , 2000, Magnetic resonance in medicine.

[24]  A. McKnight,et al.  Gabapentin inhibits the substance P-facilitated K+-evoked release of [3H]glutamate from rat caudal trigeminal nucleus slices , 2001, Pain.

[25]  J. Bryans,et al.  3‐Substituted GABA analogs with central nervous system activity: A review , 1999, Medicinal research reviews.

[26]  O. Mathiesen,et al.  ‘Protective premedication’: an option with gabapentin and related drugs? , 2004, Acta anaesthesiologica Scandinavica.

[27]  Irene Tracey,et al.  An fMRI study of cerebral processing of brush-evoked allodynia in neuropathic pain patients , 2006, NeuroImage.

[28]  Maurizio Corbetta,et al.  The human brain is intrinsically organized into dynamic, anticorrelated functional networks. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Provencher.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[30]  P. Wall,et al.  Textbook of pain , 1989 .

[31]  Vitaly Napadow,et al.  Elevated insular glutamate in fibromyalgia is associated with experimental pain. , 2009, Arthritis and rheumatism.

[32]  Rodica Pop-Busui,et al.  Altered excitation-inhibition balance in the brain of patients with diabetic neuropathy. , 2012, Academic radiology.

[33]  D. Schacter,et al.  The Brain's Default Network , 2008, Annals of the New York Academy of Sciences.

[34]  B. Orser,et al.  The Prevention of Chronic Postsurgical Pain Using Gabapentin and Pregabalin: A Combined Systematic Review and Meta-Analysis , 2012, Anesthesia and analgesia.

[35]  C. Woolf,et al.  Neuronal plasticity: increasing the gain in pain. , 2000, Science.

[36]  Jason Steffener,et al.  Functional imaging of pain in patients with primary fibromyalgia. , 2004, The Journal of rheumatology.

[37]  S. Wakana,et al.  MRI Atlas of Human White Matter , 2005 .

[38]  Jon S. C. Yu,et al.  Evidence that pregabalin reduces neuropathic pain by inhibiting the spinal release of glutamate , 2010, Journal of neurochemistry.

[39]  Kyungmo Park,et al.  Intrinsic brain connectivity in fibromyalgia is associated with chronic pain intensity. , 2010, Arthritis and rheumatism.

[40]  M. Rowbotham,et al.  Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. , 2005, Arthritis and rheumatism.

[41]  Stephen M Smith,et al.  Fast robust automated brain extraction , 2002, Human brain mapping.

[42]  M. Cunningham,et al.  Dual effects of gabapentin and pregabalin on glutamate release at rat entorhinal synapses in vitro , 2004, The European journal of neuroscience.

[43]  Ravinder Reddy,et al.  The Impact of Gabapentin Administration on Brain GABA and Glutamate Concentrations: A 7T 1H-MRS Study , 2012, Neuropsychopharmacology.

[44]  Richard E. Harris,et al.  Reduced insular γ-aminobutyric acid in fibromyalgia. , 2012, Arthritis and rheumatism.

[45]  E. Reiman,et al.  Thermosensory activation of insular cortex , 2000, Nature Neuroscience.

[46]  Katja Wiech,et al.  Prestimulus functional connectivity determines pain perception in humans , 2009, Proceedings of the National Academy of Sciences.